Precision BioSciences Opens New Manufacturing Facility in Durham
Precision BioSciences, a genome-editing company based in Durham, announced today the opening of its highly prized production facility for in-house manufacturing of its unique technologies. Calling it the Manufacturing Center for Advanced Therapeutics (MCAT), Precision…
DMC Bio, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners
DMC, an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition to its Board of Directors of Josko Bobanovic, Partner…
DIV Update: Pocket Colposcope
Nearly 300,000 women die of cervical cancer in low- and middle-income countries, about 85 percent of worldwide deaths from this disease. Early detection and treatment can prevent up to 80 percent of these cancers when…
PhaseBio: Positive Results from Phase 2a Clinical Trial of PB2452
PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor in Older and Elderly Subjects June 17, 2019 16:01 ET | Source: PhaseBio…
Lumedica looks to fine-tune low-cost OCT system with SBIR grant
Duke University spin-out wins Phase II funding to further develop device for clinical applications in low-resource settings. Lumedica, the startup company spun out of co-founder Adam Wax’s Duke University research group, has won a $1 million…
A Conversation with Lumedica’s Adam Wax
Late last month, Luminate—a Rochester, N.Y.–based startup accelerator focusing on optics, photonics and imaging technologies—announced the winners of its second-round accelerator competition. Taking third place, and taking home a cool US$250,000 of seed money from…
“Deep Sepsis” Licensed to Cohere Med
Cohere Med licenses technology from Duke to drive adoption of early Sepsis detection using AI PRESS RELEASE: 3 JULY 2019 Sepsis strikes more than a million Americans every year and 15 to 30 percent…
Phitonex Launches NovaFluor Dyes Enabling High-Res Analysis
Phitonex, Inc. launched their new suite of NovaFluor dyes today at CYTO2019, the 34th Congress of the International Society for Advancement of Cytometry, the largest industry conference in single cell biology. New dyes developed on…
Enzyvant Announces FDA Acceptance of Biologics License Application
Enzyvant Announces FDA Acceptance of Biologics License Application (BLA) and Priority Review Status for RVT-802, a Novel Investigational Tissue-Based Regenerative Therapy for Pediatric Congenital Athymia CAMBRIDGE, Mass. & BASEL, Switzerland–(BUSINESS WIRE)–Enzyvant, a biopharmaceutical company focused…